272 related articles for article (PubMed ID: 3977841)
1. The rat liver vasoactive intestinal peptide binding site. Molecular characterization by covalent cross-linking and evidence for differences from the intestinal receptor.
Couvineau A; Laburthe M
Biochem J; 1985 Jan; 225(2):473-9. PubMed ID: 3977841
[TBL] [Abstract][Full Text] [Related]
2. Molecular identification of receptors for vasoactive intestinal peptide in rat intestinal epithelium by covalent cross-linking. Evidence for two classes of binding sites with different structural and functional properties.
Laburthe M; Breant B; Rouyer-Fessard C
Eur J Biochem; 1984 Feb; 139(1):181-7. PubMed ID: 6321173
[TBL] [Abstract][Full Text] [Related]
3. Molecular identification and structural requirement of vasoactive intestinal peptide (VIP) receptors in the human colon adenocarcinoma cell line, HT-29.
Couvineau A; Rousset M; Laburthe M
Biochem J; 1985 Oct; 231(1):139-43. PubMed ID: 2998337
[TBL] [Abstract][Full Text] [Related]
4. The human vasoactive intestinal peptide receptor: molecular identification by covalent cross-linking in colonic epithelium.
Couvineau A; Laburthe M
J Clin Endocrinol Metab; 1985 Jul; 61(1):50-5. PubMed ID: 2987295
[TBL] [Abstract][Full Text] [Related]
5. Molecular characteristics and peptide specificity of vasoactive intestinal peptide receptors from rat cerebral cortex.
Couvineau A; Gammeltoft S; Laburthe M
J Neurochem; 1986 Nov; 47(5):1469-75. PubMed ID: 3020175
[TBL] [Abstract][Full Text] [Related]
6. Characterization of receptors for VIP on pancreatic acinar cell plasma membranes using covalent cross-linking.
McArthur KE; Wood CL; O'Dorisio MS; Zhou ZC; Gardner JD; Jensen RT
Am J Physiol; 1987 Mar; 252(3 Pt 1):G404-12. PubMed ID: 2435170
[TBL] [Abstract][Full Text] [Related]
7. Solubilization of the liver vasoactive intestinal peptide receptor. Hydrodynamic characterization and evidence for an association with a functional GTP regulatory protein.
Couvineau A; Amiranoff B; Laburthe M
J Biol Chem; 1986 Nov; 261(31):14482-9. PubMed ID: 3021741
[TBL] [Abstract][Full Text] [Related]
8. Covalent cross-linking of vasoactive intestinal peptide (VIP) to its receptor in intact colonic adenocarcinoma cells in culture (HT 29).
Muller JM; Luis J; Fantini J; Abadie B; Giannellini F; Marvaldi J; Pichon J
Eur J Biochem; 1985 Sep; 151(2):411-7. PubMed ID: 2992966
[TBL] [Abstract][Full Text] [Related]
9. Vasoactive intestinal peptide receptor on liver plasma membranes: solubilization and cross-linking.
Nguyen TD; Kaiser LM
Peptides; 1990; 11(6):1255-61. PubMed ID: 1965036
[TBL] [Abstract][Full Text] [Related]
10. Covalent cross-linking of vasoactive intestinal polypeptide to its receptors on intact human lymphoblasts.
Wood CL; O'Dorisio MS
J Biol Chem; 1985 Jan; 260(2):1243-7. PubMed ID: 2981838
[TBL] [Abstract][Full Text] [Related]
11. Species differences in the molecular characteristics of vasoactive-intestinal-peptide receptors in the pancreas from rat and guinea-pig.
Svoboda M; Poloczek P; Winand J; Robberecht P; Christophe J
Eur J Biochem; 1988 May; 174(1):59-66. PubMed ID: 2836201
[TBL] [Abstract][Full Text] [Related]
12. Functional and immunological evidence for stable association of solubilized vasoactive-intestinal-peptide receptor and stimulatory guanine-nucleotide-binding protein from rat liver.
Couvineau A; Rouyer-Fessard C; Voisin T; Laburthe M
Eur J Biochem; 1990 Feb; 187(3):605-9. PubMed ID: 2154377
[TBL] [Abstract][Full Text] [Related]
13. Evidence for the formation of a functional complex between vasoactive intestinal peptide, its receptor, and Gs in lung membranes.
Kermode JC; DeLuca AW; Zilberman A; Valliere J; Shreeve SM
J Biol Chem; 1992 Feb; 267(5):3382-8. PubMed ID: 1310685
[TBL] [Abstract][Full Text] [Related]
14. Characterization and solubilization of vasoactive intestinal peptide receptors from rat lung membranes.
Provow S; Veliçelebi G
Endocrinology; 1987 Jun; 120(6):2442-52. PubMed ID: 3032591
[TBL] [Abstract][Full Text] [Related]
15. Pharmacology, molecular identification and functional characteristics of vasoactive intestinal peptide receptors in human breast cancer cells.
Gespach C; Bawab W; de Cremoux P; Calvo F
Cancer Res; 1988 Sep; 48(18):5079-83. PubMed ID: 2842044
[TBL] [Abstract][Full Text] [Related]
16. HT 29, a model cell line: stimulation by the vasoactive intestinal peptide (VIP); VIP receptor structure and metabolism.
Marchis-Mouren G; Martin JM; Luis J; el Battari A; Muller JM; Marvaldi J; Pichon J
Biochimie; 1988 May; 70(5):663-71. PubMed ID: 2844304
[TBL] [Abstract][Full Text] [Related]
17. Characterization of vasoactive intestinal peptide receptors on rat alveolar macrophages.
Sakakibara H; Shima K; Said SI
Am J Physiol; 1994 Sep; 267(3 Pt 1):L256-62. PubMed ID: 7943252
[TBL] [Abstract][Full Text] [Related]
18. Solubilization and hydrodynamic characterization of guanine nucleotide sensitive vasoactive intestinal peptide-receptor complexes from rat intestine.
Calvo JR; Couvineau A; Guijarro L; Laburthe M
Biochemistry; 1989 Feb; 28(4):1667-72. PubMed ID: 2541761
[TBL] [Abstract][Full Text] [Related]
19. Characterization of vasoactive intestinal peptide receptors in human liver.
Rodríguez-Henche N; Rodríguez-Pena MS; Guijarro LG; Prieto JC
Biochim Biophys Acta; 1994 Mar; 1221(2):193-8. PubMed ID: 8148398
[TBL] [Abstract][Full Text] [Related]
20. Molecular characteristics and evidence for internalization of vasoactive-intestinal-peptide (VIP) receptors in the tumoral rat-pancreatic acinar cell line AR 4-2 J.
Svoboda M; De Neef P; Tastenoy M; Christophe J
Eur J Biochem; 1988 Oct; 176(3):707-13. PubMed ID: 2844535
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
